Back

BCOR mutations establish a persistent culture-adaptive state in human induced pluripotent stem cells

Badja, C.; Boushaki, S.; Kumar, Y.; Roumeliotis, T. I.; Curle, A. J.; Guiloff, A. E.; Degasperi, A.; Momen, S.; Robert, F.; Memari, Y.; Shooter, S.; Kozik, Z.; Zhao, S. J.; Toong, P. J.; Baker, I.; Hendrich, B.; Barker, R. A.; Choudhary, J.; Koh, G. C. C.; Nik-Zainal, S.

2026-09-07 cell biology
10.64898/2026.09.04.739550 bioRxiv
Show abstract

Human induced pluripotent stem cells (hiPSCs) are widely used for disease modelling and regenerative medicine, yet their utility depends on maintaining molecular integrity during long-term culture. BCOR (BCL6 Co-Repressor) mutations are among the most recurrent culture-acquired alterations in hiPSCs, but their functional consequences remain poorly understood. Here, we show that hiPSC BCOR mutations are predominantly truncating indels enriched in exon 7, defining a mutational landscape distinct from that observed in cancer. Multi-omics profiling reveals that BCOR loss drives widespread chromatin, transcriptomic and proteomic remodelling, with coordinated activation of developmental, pluripotency-associated and mitochondrial metabolism programmes. To facilitate routine surveillance, we develop a cost-effective TaqMan qPCR assay that accurately identifies BCOR-mutant hiPSCs across independent cell lines. Finally, we demonstrate that correction of BCOR mutation by CRISPR-Cas9 only partially restores the wildtype molecular state, highlighting the importance of early detection and monitoring of adaptive mutations in hiPSC cultures.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.